More Info

General Info
Pharmos discovers and develops novel therapeutics to treat a range of indications that include neurological and inflammatory disorders. The company's core proprietary technology platform focuses on the discovery and development of synthetic cannabinoid compounds. Cannabinor, the company s lead CB2-selective receptor agonist candidate, is scheduled for Phase II testing in pain indications during 2006. Other compounds from Pharmos' proprietary synthetic cannabinoid library are in preclinical studies targeting pain, multiple sclerosis, rheumatoid arthritis and other disorders. Pharmos is headquartered in Iselin, N.J.
Location
Metro Corporate Campus I
Categories

Reviews

Hi there!
Be the first to review!
What do you rate this business?First-classBetter than mostAbout what I expectedNot the worst...Disappointing
Click to Rate

Details

Address: 99 Wood Ave S Ste 302, Iselin, NJ 08830

More Like This